| Product Name | MF | CAS | Details |
|---|
| Epitinib succinate | C28H32N6O6 | 2252334-12-4 | Details |
| STING agonist-12 | C25H19ClF4N2O2 | 2259624-71-8 | Details |
| JQAD1 | C48H52F4N6O9 | 2417097-18-6 | Details |
| Matairesinoside | C26H32O11 | 23202-85-9 | Details |
| DI-591 | C31H47N5O4S | 2245887-38-9 | Details |
| MARK4 inhibitor 1 | C20H18N6O3 | 2271081-58-2 | Details |
| M2N12 | C20H16ClN5O2 | 2376577-06-7 | Details |
| G140 | C17H16Cl2N4O2 | 2369751-07-3 | Details |
| E64FC26 | C19H23F3O2 | 2285446-62-8 | Details |
| HWL-088 | C22H19FO4 | 2378617-96-8 | Details |
| IHMT-PI3Kδ-372 | C26H23F2N7O2 | 2429889-62-1 | Details |
| IL-17 modulator 4 | C27H34N6O2 | 2446803-65-0 | Details |
| NF-κΒ activator 1 | C16H11FN2O2S | 2387524-59-4 | Details |
| KB-0742 dihydrochloride | C16H26ClN5 | 2416874-75-2 | Details |
| Evifacotrep | C18H12ClF4N5O2 | 2413739-88-3 | Details |
| EZM0414 | C22H29FN4O2 | 2411748-50-8 | Details |
| ACSS2-IN-2 | C21H19F2N3O4 | 2332820-04-7 | Details |
| DDO-7263 | C14H9F2N3O | 2254004-96-9 | Details |
| SM-360320 | C15H17N5O3 | 226907-52-4 | Details |
| C16-Ceramide | C34H67NO3 | 24696-26-2 | Details |
| Bractoppin | C25H23FN4O | 2290527-07-8 | Details |
| Maralixibat chloride | C40H56ClN3O4S | 228113-66-4 | Details |
| JAK2/FLT3-IN-1 | C25H34FN7O | 2387765-27-5 | Details |
| SARS-CoV-2 Mpro-IN-9 | C22H22O11 | 244285-12-9 | Details |
| 15-LOX-1 inhibitor 1 | C22H21ClN2O4 | 2349374-37-2 | Details |
| Lufotrelvir | C24H33N4O9P | 2468015-78-1 | Details |
| GSK778 | C30H33N5O3 | 2451862-42-1 | Details |
| Camonsertib | C21H26N6O3 | 2417489-10-0 | Details |
| BAY 2666605 | C17H12F4N2O2 | 2275774-60-0 | Details |
| BRM/BRG1 ATP Inhibitor-2 | C20H20N4O2S2 | 2368900-77-8 | Details |
| Terameprocol | C22H30O4 | 24150-24-1 | Details |
| Cathepsin inhibitor 1 | C20H24ClN5O2 | 225120-65-0 | Details |
| 2-Phenylethyl isothiocyanate | C9H9NS | 2257-09-2 | Details |
| BTK inhibitor 10 | C25H23N5O3 | 2241732-30-7 | Details |
| WDR5-IN-1 | C30H31FN4O3 | 2408842-51-1 | Details |
| HPK1-IN-7 | C24H22N6O4 | 2320462-65-3 | Details |
| BAY-3827 | C27H25FN6O | 2377576-35-5 | Details |
| IDRA 21 | C8H9ClN2O2S | 22503-72-6 | Details |
| BAY-6035 | C22H28N4O3 | 2247890-13-5 | Details |
| Adaphostin | C24H27NO4 | 241127-58-2 | Details |
| VULM 1457 | C25H27N3O3S | 228544-65-8 | Details |
| Evixapodlin | C34H36Cl2N8O4 | 2374856-75-2 | Details |
| Pratensein | C16H12O6 | 2284-31-3 | Details |
| ATX inhibitor 5 | C22H18ClF3N6O | 2402772-45-4 | Details |
| CU-115 | C21H11F7INO2 | 2471982-20-2 | Details |
| PF-07220060 | C22H27ClFN5O3 | 2380321-51-5 | Details |
| BMS-986299 | C18H19N7O | 2242952-69-6 | Details |
| EB-42486 | C22H22N8O | 2390475-81-5 | Details |
| MERS-CoV-IN-1 | C19H17NO2 | 2245697-92-9 | Details |
| GA-017 | C18H21N3O4 | 2351906-74-4 | Details |
| YS-370 | C37H35BrN4O3 | 2470908-79-1 | Details |
| Geranylgeraniol | C20H34O | 24034-73-9 | Details |
| ZX-29 | C23H28ClN7O3S | 2254805-62-2 | Details |
| (S)-Sunvozertinib | C29H35ClFN7O3 | 2370013-49-1 | Details |
| TP0586532 | C26H28N4O4 | 2427584-96-9 | Details |
| Migoprotafib | C25H26N8O | 2377352-49-1 | Details |
| Cyclothiazide | C14H16ClN3O4S2 | 2259-96-3 | Details |
| Alloxan hydrate | C4H4N2O5 | 2244-11-3 | Details |
| Nampt-IN-5 | C25H25N5O2 | 2380013-17-0 | Details |
| Reverse transcriptase-IN-1 | C25H17N7O2 | 2380001-43-2 | Details |
| CDK12-IN-2 | C32H32N6O2 | 2244987-03-7 | Details |
| JR14a | C25H26Cl2N4O3S | 2411440-41-8 | Details |
| Sovilnesib | C26H34F2N6O4S | 2410796-79-9 | Details |
| Menin-MLL inhibitor 20 | C33H40N8O4 | 2448173-47-3 | Details |
| Djalonensone | C15H12O5 | 23452-05-3 | Details |
| Anhydroerythromycin A | C37H65NO12 | 23893-13-2 | Details |
| MAGL-IN-1 | C22H24FNO3 | 2324160-91-8 | Details |
| Enbezotinib | C21H21FN6O3 | 2359649-81-1 | Details |
| FLT3-IN-4 | C23H25N7O2 | 2304799-09-3 | Details |
| MS31 | C20H27N3O2 | 2366264-12-0 | Details |
| PARP/PI3K-IN-1 | 2337386-47-5 | Details |
| PD-1/PD-L1-IN-NP19 | C33H31ClN2O4 | 2377916-66-8 | Details |
| IHMT-MST1-58 | C21H22N6O3S | 2414484-25-4 | Details |
| Monaschromone | C30H44O3 | 22611-36-5 | Details |
| ASK1-IN-1 | C19 H19 N9 O2 | 2411382-24-4 | Details |
| HS271 | C21H24F3N5O2 | 2410393-15-4 | Details |
| SY-5609 | C23H26F3N6OP | 2417302-07-7 | Details |
| Zanzalintinib | C29H25FN4O5 | 2367004-54-2 | Details |
| Pumecitinib | C17H20N8O2S | 2401057-12-1 | Details |
| IU1-248 | C20H23N3O2 | 2307472-03-1 | Details |
| PLN-1474 | C24H37N3O4 | 2408065-32-5 | Details |
| AES-135 | C33H29F6N3O5S | 2361659-61-0 | Details |
| RBN-3143 | C22H28FN3O4S | 2360853-16-1 | Details |
| CAY10746 | C26H23N3O5 | 2247240-76-0 | Details |
| VU6015929 | C24H19F4N5O2 | 2442597-56-8 | Details |
| Palmitic acid- | C27H34N2O5 | 2411429-33-7 | Details |
| SCR130 | C19H13Cl2N3O2S | 2377858-38-1 | Details |
| SU056 | C20H16FNO5 | 2376580-08-2 | Details |
| CMPD-39 | C26H28FN3O4S | 2242582-40-5 | Details |
| Tuspetinib | C29H33ClN6 | 2294874-49-8 | Details |
| WEE1-IN-5 | C26H28Cl2N6O | 2243882-74-6 | Details |
| JKE-1674 | C20H20Cl2N4O4 | 2421119-60-8 | Details |
| SN-008 | C25H19FN2O3S | 2249106-01-0 | Details |
| HeE1-2Tyr | C33H30N2O6S | 2245195-67-7 | Details |
| JNJ4796 | C28H27N9O3 | 2241664-16-2 | Details |
| CA77.1 | C16H12ClN3O | 2412270-22-3 | Details |
| IL-17A inhibitor 1 | C24H27F5N8O4 | 2452464-73-0 | Details |
| XL177A | C48H57ClN8O5 | 2417089-74-6 | Details |
| G6PDi-1 | C14H12N4OS | 2457232-14-1 | Details |
| STING-IN-3 | C17H20N2O4 | 2244881-69-2 | Details |
| Product Total： Product Page： | ||||
| 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 | ||||